logo
Woman has burning sensation in legs after vacation — then doctors find brain parasites

Woman has burning sensation in legs after vacation — then doctors find brain parasites

Miami Herald21-02-2025

After a three-week-long vacation through Thailand, Japan and Hawaii, a 30-year-old woman learned she brought home an unwelcome souvenir, doctors said.
When the woman first returned home to the coast of New England, she felt fatigued and attributed it to jet lag from weeks of traveling, according to a Feb. 13 case report published in the New England Journal of Medicine.
Her lack of energy was accompanied by a slight burning sensation in her feet, according to the case report, and she took some ibuprofen to help alleviate the pain.
The medications were unsuccessful, and over the next eight days, the burning sensation spread up her body into her legs, doctors said.
The pain got worse when her legs were touched, according to the report, and she went to the emergency room.
Burning spreads to the chest
The woman went through a series of tests — she had a normal temperature, heart rate, blood pressure and blood oxygen saturation — and she was sent home with instructions to follow up with her primary care physician, doctors said.
But over the next three days, the burning feeling spread up to her chest and arms and she developed a headache that wouldn't wane even with over-the-counter pain medication, according to the report.
The woman went back to the emergency room, but again showed normal tests, so she was given intravenous pain medications that helped her still-pounding headache and was sent home with the same instructions, doctors said.
'After the patient arrived home from the emergency department, she took zolpidem ((a drug for insomnia) which had been prescribed for a family member) to help with sleep. On the day of the current presentation, confusion developed,' doctors said. 'In the morning when she awoke, she thought she needed to pack for vacation and was not redirectable when her roommate attempted to help her lie back down in bed. When confusion did not resolve after several hours, the patient's partner brought her to this hospital for further evaluation.'
Sushi, street food-filled vacation
Then, doctors learned more about her trip.
In Bangkok, Thailand, she toured the city and stopped for street food along the way, but said she didn't eat anything raw, according to the report. Her next stop was Tokyo, Japan, where she said she mainly stayed in the hotel, but ate sushi throughout her stay. The majority of her trip was spent in Hawaii swimming in the ocean and eating salads and sushi.
Her newly developed confusion led doctors to try new tests, including a lumbar puncture, a procedure that taps into the spine to test the cerebrospinal fluid, according to the report.
The fluid underwent a diagnostic test, and finally the woman had an answer — she had parasites in her brain.
Doctors discovered Angiostrongylus cantonensis, a parasitic species of roundworm also called rat lungworm.
An A. cantonensis infection can lead to human eosinophilic meningitis, which the woman was experiencing.
'Human infection, which was initially described in Taiwan, is now distributed across many tropical and subtropical regions in southeast Asia and the Pacific Islands (including Hawaii), with expanding distribution that now includes locally acquired infections in Europe, Australia, the southern United States and the Caribbean,' doctors said. 'Only five cases of angiostrongyliasis were confirmed in Hawaii in 2024; however, given that 9 to 10 million tourists visit Hawaii each year, many people may have been exposed to infection but may not have symptoms until after they leave Hawaii.'
The infection can come from a few sources: raw or undercooked snails or slugs, vegetables or fruit that have been contaminated by snails, slugs or flatworms or their slime, or by eating infected hosts like land crabs, freshwater prawns or frogs, doctors said.
It can take as many as 14 days after the parasites are ingested for symptoms to begin, according to the report.
Symptoms usually begin as headache, nausea, vomiting and fever, but then can spread to neurological symptoms after the parasite leaves the bloodstream, enters muscle, migrates to peripheral nerves and into the spinal column and brain, doctors said.
The woman was treated with a directed therapy of medications — albendazole, prednisone, gabapentin and amitriptyline — and her headache and burning sensation went away, doctors said. She was able to return home after six days in the hospital to recover.
The medical team includes Joseph Zunt, Amy K. Barczak and Daniel Y. Chang.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What to know about Ozempic: Diabetes drug used off-label for weight loss sparks warnings
What to know about Ozempic: Diabetes drug used off-label for weight loss sparks warnings

Yahoo

time11-06-2025

  • Yahoo

What to know about Ozempic: Diabetes drug used off-label for weight loss sparks warnings

KUALA LUMPUR, June 11 — As global interest in weight loss remedies grows, the off-label use of diabetes medication Ozempic for shedding pounds in non-diabetic individuals has emerged as a trend. This rising popularity, fuelled by social media and anecdotal success stories, has prompted medical professionals to caution against its unsupervised use. Here's what you need to know about Ozempic, its side effects, and why expert supervision is essential before considering it for weight loss. What is Ozempic? Ozempic is a medication primarily approved for managing type 2 diabetes. Its active ingredient, semaglutide, mimics a hormone that targets areas of the brain involved in appetite regulation. Initially designed for diabetes treatment, Ozempic has gained popularity as a weight loss aid, even among non-diabetic individuals. Can Ozempic be used for weight loss? According to Universiti Teknologi MARA consultant endocrinologist Prof Dr Rohana Abdul Ghani, Ozempic is not intended for use as a weight loss medication for non-diabetic patients. 'Ozempic is approved in Malaysia specifically for managing type 2 diabetes. However, semaglutide's weight loss benefits have led some to seek it off-label for obesity treatment,' she said. For non-diabetic patients, semaglutide should be administered at a higher dose of 2.4mg weekly under another brand name, which is unavailable in Malaysia, she added. 'The off-label use of Ozempic among non-diabetic patients has led to a shortage for those with type 2 diabetes and reduced efficacy due to the lower dose,' said Dr Rohana. She also highlighted studies suggesting that regular use of weight loss drugs might establish a 'new normal' in the body, potentially leading to weight gain. One study in the New England Journal of Medicine found that low doses of semaglutide (between 0.25mg and 0.5mg) were linked to weight gain in some patients. What are the potential side effects? As with any medication, Ozempic comes with potential side effects. Dr Rohana said common gastrointestinal side effects include nausea, vomiting, constipation, or diarrhoea, which are typically self-limiting and subside within one to two weeks. She added that rare side effects include skin reactions at the injection site and worsening eyesight, particularly in patients with high blood sugar experiencing rapid improvement. 'Ozempic should not be used by patients with a history of thyroid cancer due to the rare risk of pancreatitis,' she said. Who shouldn't take Ozempic without medical advice? Dr Rohana stressed that no one should take Ozempic without consulting a doctor. 'Medications like Ozempic for obesity should be paired with proper diet and lifestyle changes. Without these, there's a risk of complications such as significant muscle mass loss or kidney issues from severe vomiting,' she said. 'These medications should only be prescribed by clinicians who are familiar with their effects and risks,' she added.

The Best Father's Day Gift
The Best Father's Day Gift

Epoch Times

time10-06-2025

  • Epoch Times

The Best Father's Day Gift

After the nurse took my blood pressure and left the room, I waited alone for the arrival of my physician. At my age, this particular moment of an annual physical can bring some long thoughts. What if this was the visit where my doctor said, 'Well, Jeff, I'm afraid I have some bad news'? I began planning how I would tell my children and friends of my impending demise. As I paced the small room, I stopped by the magazine rack, where there were several copies of 'People' and even a 'New England Journal of Medicine.' There was also a Bible. As I opened it, my finger fell on Proverbs 17:6: 'Children's children are the crown of old men; and the glory of children are their fathers.'

California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs
California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs

Yahoo

time09-06-2025

  • Yahoo

California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs

The proliferation of new fungicides in the U.S. agricultural sector may be raising resistance to critical antifungal medications in humans and animals, infectious disease experts are warning. Although antifungal pesticides have become vital to combatting the spread of crop disease, the ongoing development of new such fungicides may be leaving people more vulnerable to severe infections, according to new commentary published in the New England Journal of Medicine. 'Antimicrobial resistant pathogens are a constant reminder for us to use agents judiciously,' lead author George Thompson, a professor of medicine at the University of California, Davis, said in a statement. 'We have learned that the widespread use of antibiotics for livestock resulted in the rapid development of resistance to antibacterials,' Thompson continued. 'We have similar concerns regarding the use of antifungals in the environment.' In the past few decades, fungi that cause severe infections in humans — such as the difficult-to-treat Candida auris — have undergone a rapid increase, the scientists noted. Yet because there are relatively few antifungals available to eradicate such microbes from the body, Thompson stressed that 'preventing resistance is of paramount importance.' In the U.S. today, the researchers found that there are about 75,000 hospitalizations and 9 million outpatient visits linked to fungal diseases every year, with direct annual costs amount to $6.7 billion to $7.5 billion. At the same time, the U.S. Department of Agriculture estimates that fungi cause between 10 percent to 20 percent of crop loss, at a cost of $100 billion to $200 billion annually, according to the report. However, scientists have now become increasingly aware that antifungal pesticides and antifungal drugs share some of the same mechanisms. The authors therefore warned that the promulgation of these chemicals 'may select for resistant fungi in the environment, which can then endanger human health.' The development of antifungal medications, meanwhile, is a difficult task due to the metabolic similarities shared by human and fungal cells, as well as the surge in antifungal resistance, the authors explained. Tackling this problem, they contended, requires what's known as a 'One Health' approach — a state that recognizes how human, animal and environmental health are all related. As scientists research future solutions, having representatives from each of these sectors in the room will be increasingly critical, the commentary argued. Shared decision-making among national and global regulators, the researchers added, would both be cost-effective and would help avoid the 'riskier prospects of the rapid spread of resistant pathogens.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store